Company Announcements

Thermo Fisher Scientific announced in November 2009 that Inverness Medical Innovations ended its supply agreement for Biosite diagnostic products effective July. Annual revenues from the agreement are expected to be $200 million in 2009 and less than half of that in 2010. An agreement with a new supplier is expected to generate $40 million in sales in 2010.

Pall inaugurated its new European headquarters in Fribourg, Switzerland, in November.

Halma Health and Analysis reported revenues for the half year ended September 2009 rose 9.5% to £83.6 million ($132.8 million) and declined 10% organically at constant currency. Operating profit grew 11.9% to £15.9 million ($25.2 million) (see IBO 12/15/09).

Nine-month 2009 revenue for Roche Applied Science increased 12% to CHF 616 million ($555 million), including third-quarter growth of 21%. Nucleic acid purification product sales rose 24%, Array sales grew 39%, Sequencing sale increased 12%, Industrial sales grew 1% and sales of “Other” products increased 12%. North American and Rest of World sales increased 5% and 19%, respectively, while sales in Europe, Middle East and Africa grew 17%.

Danaher named Elias A. Zerhouni, MD, former director of the National Institutes of Health, to its Board in December 2009.

Ruediger Naumann-Etienne resigned from Bio-Rad Laboratories’ Board in December 2009.

Thermo Fisher Scientific plans to add 116 jobs to its plant in Marietta, Ohio, following the award of Job Creation Tax Credits. The plant manufactures specialty cold storage equipment.

For the year ended September 2009, Analytik Jena AG’s revenues rose 4.3% to €71.1 million ($96.1 million). Excluding the discontinued Project business, sales grew 10.3%. Operating profit rose 33.1% to €6.3 million ($8.5 million). Analytical Solutions sales rose 15.9% to €46.6 million ($63.0 million). Bio Solutions sales increased 314.1% to €17.9 million ($24.2 million) due to acquisitions (see IBO 3/15/09, 4/30/09) and grew 22.1% excluding acquisitions. Optical Solutions revenue fell 22.4% to €6.6 million ($8.9 million). Sales in Germany, America and Asia grew 27.4%, 50.4% and 47.6%, respectively, to 33%, 9% and 33% of revenues. Sales fell 38.7% in Europe and declined 52.1% in Rest of World to 23% and 2% of revenues, respectively. The company increased its stake in Cybio AG to 73% in November 2009, but noted that the integration of the business had been more difficult than expected.

In January, Pfeiffer Vacuum Technology AG acquired Trinos Vakuum-Systeme GmbH, which had fiscal 2008 sales of €18 million ($27 million) and has 140 employees.

Sales/Orders of Note

The International Cooperation to Sequence the Atlantic Salmon Genome awarded Beckman Coulter Genomics the contract for phase one of the project.